A Multi-Center Post-Marketing Surveillance Study of Recombinant Factor VIII (Recombinate) in Previously Treated Patients With Hemophilia A

Japanese Journal of Thrombosis and Hemostasis
doi 10.2491/jjsth.16.650
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society on Thrombosis and Hemostasis

Related search

A Long-Term, Multi-Center Clinical Study of Recombinant Human Factor VIII BAY W 6240) in Treatment of Hemophilia A.

Journal of the Japan Society of Blood Transfusion
1991English

AMulticenter Clinical Study of Recombinant Factor VIII (BL-160) in Hemophilia a Patients

Japanese Journal of Thrombosis and Hemostasis
1993English

Study on Oral Hemorrhagic Management in Patients With Blood Disease. Report 22. A Case of Hemophilia a Receiving Recombinant Human Factor VIII.

Japanese Journal of Oral & Maxillofacial Surgery
1995English

Perioperative Management of Hemophilia a Using Recombinant Factor VIII in Patients Undergoing Major or Minor Surgery

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Real-World Health Care Expenditure in Hemophilia a Patients Using Standard and Extended Half-Life Recombinant Factor VIII Products

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Features of Factor VIII Activity Measurement in Arg531His Mutant Detected in Patients With Mild Hemophilia A

Japanese Journal of Thrombosis and Hemostasis
2008English

Effect of Route of Administration of Human Recombinant Factor VIII on Its Immunogenicity in Hemophilia a Mice

Journal of Pharmaceutical Sciences
Pharmaceutical Science
2009English

Multicenter Clinical Study of a Highly Purified Porcine Factor VIII Concentrate [MTI-9002 (Hyate: C)] in Hemophilia a Patients With Inhibitor

Japanese Journal of Thrombosis and Hemostasis
1991English

The Impact of Factor VIII/von Willebrand Factor Products in Inhibitor Development and Management of Patients With Hemophilia a With Inhibitors

Oncology & Hematology Review (US)
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy